June 16, 2015—If policymakers were to decide to reduce Medicare payments for Part B drugs bought by 340B hospitals, they may want to let those hospitals keep a share of their 340B savings as an incentive to stay in the program, congressional Medicare policy advisers say in a new report.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)